Doha: Sidra Medicine has announced a medical achievement by facilitating access to sepiapterin for patients with Phenylketonuria (PKU), making Qatar ...
Qatar Third Globally To Offer Breakthrough Treatment. Sidra Medicine has marked a significant medical achievement by securing regulated access to sepiapterin for patients with Phenylketonuria (PKU), p ...
Sidra Medicine introduces groundbreaking sepiapterin treatment for Phenylketonuria (PKU) patients in Qatar, becoming the ...
Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that China's National Medical Products Administration ...
University of Doha for Science and Technology (UDST) has announced the launch of three new academic programmes for Fall 2026.
MDR-001 progressed from program discovery to Phase III in just 4.5 years, much faster than traditional development cycles.Phase IIb data ...
TipRanks on MSN
BrainAurora expands digital mental-health footprint with new hospital alliances and approved Beijing Key Laboratory
BrainAurora Medical Technology Limited ( ($HK:6681) ) has provided an update. BrainAurora Medical Technology has entered into major cooperation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback